Kyowa Kirin Co., Ltd. (KY4.F) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13.60

Open14.50

Day range—

52-week range11.7015.70

Off day high0.00%

Off 52-week high−7.64%

Volume440

Avg. volume (3M)28.00

Market cap7.59B

EPS (TTM)0.8600

Forward P/E17.68

P/E ratio (TTM)16.86

Dividend yield2.89% (0.4000)

Beta (5Y)0.22

Shares outstanding523.59M

Short interest—

Earnings dateNov 2, 2026

Analyst target—

Profit margin15.35%

Against its peers

Compare in full ›

	KY4.F	KNSA	300558.SZ	GUD.TO	HCM	42C.SI
Market cap	7.59B	7.55B	20.76B	1.11B	2.42B	515.12M
P/E (TTM)	16.9	72.8	77.9	75.3	139.2	—
Forward P/E	17.7	44.0	29.2	43.5	53.7	247.4
Price/book	1.5	10.6	3.2	1.4	1.9	33.6
Dividend yield	2.89%	—	0.31%	—	—	—
1-year change	+1.49%	+148.82%	−12.57%	+86.16%	−9.90%	+259.26%
Today	+6.62%	+3.03%	+1.62%	+0.36%	+6.42%	−3.09%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Kyowa Kirin's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Kiniksa Pharmaceuticals International, plcKNSA · Drug Manufacturers - Specialty & Generic	7.55B	96.12	+3.03%
Betta Pharmaceuticals Co., Ltd.300558.SZ · Drug Manufacturers - Specialty & Generic	20.76B	49.05	+1.62%
Knight Therapeutics Inc.GUD.TO · Drug Manufacturers - Specialty & Generic	1.11B	11.30	+0.36%
HUTCHMED (China) LimitedHCM · Drug Manufacturers - Specialty & Generic	2.42B	13.92	+6.42%
iX Biopharma Ltd.42C.SI · Drug Manufacturers - Specialty & Generic	515.12M	0.4700	−3.09%
Kamada Ltd.KMDA · Drug Manufacturers - Specialty & Generic	428.21M	7.42	+2.34%
Akebia Therapeutics, Inc.AKBA · Drug Manufacturers - Specialty & Generic	192.51M	0.6947	−4.28%
Kura Oncology, Inc.KURA · Biotechnology	676.99M	7.61	−22.98%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Kilitch Drugs (India) LimitedKILITCH.NS · Mumbai, India	7.29B	208.47	−0.21%
Renhe Pharmacy Co.,Ltd000650.SZ · Nanchang, China	7.24B	5.17	+0.39%
Kiniksa Pharmaceuticals International, plcKNSA · London, United Kingdom	7.55B	96.12	+3.03%
SSY Group Limited2005.HK · Wan Chai, Hong Kong	7.63B	2.655	+1.34%
Amneal Pharmaceuticals, Inc.AMRX · Bridgewater, NJ	6.95B	19.95	−1.29%
Guangxi Wuzhou Zhongheng Group Co., Ltd600252.SS · Wuzhou, China	7.13B	2.2400	+2.28%
Jiuzhitang Co., Ltd.000989.SZ · Beijing, China	7.34B	8.57	+1.66%
Jiangsu Kanion Pharmaceutical Co.,Ltd.600557.SS · Lianyungang, China	7.26B	12.83	+0.39%

Healthcare companies of a similar market value (7.23B).

Company	Mkt cap	Price	Today
China Resources Boya Bio-pharmaceutical Group Co.,Ltd300294.SZ · Biotechnology	7.26B	14.40	+0.84%
Adimmune Corporation4142.TW · Biotechnology	7.00B	16.60	−2.35%
Kilitch Drugs (India) LimitedKILITCH.NS · Drug Manufacturers - Specialty & Generic	7.29B	208.47	−0.21%
Renhe Pharmacy Co.,Ltd000650.SZ · Drug Manufacturers - Specialty & Generic	7.24B	5.17	+0.39%
Daan Gene Co., Ltd.002030.SZ · Biotechnology	7.56B	5.39	+0.94%
InventisBio Co., Limited688382.SS · Biotechnology	8.38B	14.45	+4.33%
Bausch + Lomb CorporationBLCO · Medical Instruments & Supplies	7.36B	20.60	+2.85%
Nanjing Xinjiekou Department Store Co., Ltd.600682.SS · Medical Care Facilities	7.24B	5.38	+0.75%

Also based in Chiyoda, Japan, then elsewhere in Japan.

Company	Mkt cap	Price	Today
Mitsubishi UFJ Financial Group, Inc.MUFG · Chiyoda, Japan	247.29B	21.97	+3.29%
Advantest CorporationVAN.F · Chiyoda, Japan	119.94B	166.10	−13.51%
Mizuho Financial Group, Inc.MFG · Chiyoda, Japan	118.31B	9.80	+2.73%
Tokio Marine Holdings, Inc.8766.T · Chiyoda, Japan	17.10T	606.00	+4.72%
Mitsui & Co., Ltd.8031.T · Chiyoda, Japan	14.29T	5,039.00	+2.84%
NTT, Inc.9432.T · Chiyoda, Japan	13.32T	164.90	+0.55%
Mitsubishi Heavy Industries, Ltd.7011.T · Chiyoda, Japan	10.26T	3,052.00	−6.15%
Mitsubishi Electric Corporation6503.T · Chiyoda, Japan	9.72T	4,751.00	−1.25%

Companies that serve the same markets: industrial.

Company	Mkt cap	Price	Today
PT Samcro Hyosung Adilestari TbkACRO.JK · industrial	156.12B	45.00	+4.65%
Riken Keiki Co., Ltd.7734.T · industrial	154.10B	3,390.00	−1.74%
HB Technology CO.,LTD.078150.KQ · industrial	153.09B	1,722.00	−5.64%
Trane Technologies plc0Y2S.IL · industrial	211.82B	402.99	+357.06%
Seoho Electric Co.,Ltd065710.KQ · industrial	223.99B	44,500.00	+0.68%
Klabin S.A.KLBN11.SA · industrial	128.48B	18.08	+4.03%
Empresas CMPC S.A.CMPC.SN · industrial	2.26T	904.00	−2.48%
Astor Enerji A.S.ASTOR.IS · industrial	159.98B	160.30	−3.26%

What visitors to Kyowa Kirin's page also look at.

Company	Mkt cap	Price	Today
CHUGAI PHARMACEUTICAL CO. LTD.RCUP.F	65.86B	40.02	+4.33%
CSPC Pharmaceutical Group Ltd.RCVG.F	10.81B	0.9478	+3.60%
Daiichi Sankyo Co. Ltd.D4S.F	31.06B	17.05	+5.64%
Astellas Pharma Inc.YPH.F	26.36B	14.70	+5.76%
EISAI CO. LTD.EII.F	8.28B	29.32	+5.92%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All KY4.F news ›

Seeking Alpha·3d agoPositive

Kyowa Kirin Non-GAAP EPS of ¥147.83, revenue of ¥384.95B; reaffirms FY2026 outlook

Kyowa Kirin Q3 results show EPS of ¥147.83 and revenue up 10.2% YoY to ¥384.95B. - Kyowa Kirin press release (KYKOF): for the nine months ended September 30, 2026 Non-GAAP EPS of ¥147.83. More on Kyowa Kirin Co., Ltd.

KD KYOCF KARO KRC

@PRNewswire·4d ago

Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis

THOUSAND OAKS, Calif. and TOKYO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Amgen (NASDAQ: AMGN) and Kyowa Kirin Co., Ltd. (TSE:4151) today announced preliminary top-line results from the ASCEND study evaluating rocatinlimab, an investigational…

LLY PFE NVS

WRAL News·4d agoNegative

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Stock quotes, market indicators and the latest market news. Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1-m AML who have no satisfactory…

BMY AZN JNJ

MarketScreener·Oct 26Positive

Cognizant to Support Kyowa Kirin's AI R&D Platform in Japan

Cognizant Technology Solutions will provide end-to-end support for the development and implementation of an artificial intelligence platform for research and development at Tokyo Research Park and... Cognizant Technology Solutions…

CTSH NVDA DELL APO

markets.businessinsider.com·Oct 19Negative

Kyowa Kirin downgraded to Hold from Buy at Jefferies

Jefferies downgraded Kyowa Kirin (KYKOF) to Hold from Buy with a price target of 2,600 yen, down from 2,800 yen, following “disappointing” Phase... Kyowa Kirin downgraded to Hold from Buy at Jefferies Jefferies downgraded Kyowa Kirin…

KKR JEF

markets.businessinsider.com·Oct 19Positive

Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin

Knight Therapeutics (KHTRF) announced the signing of an exclusive distribution agreement with Kyowa Kirin International, a wholly owned subsidia... Knight Therapeutics signs exclusive distribution agreement with Kyowa Kirin Knight…

KURA KLRS NKTR KYTX

markets.businessinsider.com·Oct 19

The XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH

While the XLH Community Guidebook began as a joint effort between the XLH Network and Kyowa Kirin, future editions will be managed solely by the XLH Network following the site's transition at the end of 2026. The Guidebook content spans…

From the 4Search news index, newest first.

In the news

6mentions in 30 days

6with it in the headline

Positivesentiment

Most coverage from

markets.businessinsider.com3
markets.financialcontent.com1
marketscreener.com1
seekingalpha.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.